Intellia Therapeutics Current Deferred Revenue (Quarterly) Trends

Intellia Therapeutics, Inc. (NTLA)

9.14 -0.30 (-3.18%) USD | NASDAQ | Dec 29, 16:00

9.18 +0.04 (+0.44%) After-Hours: 07:36

View Current Deferred Revenue (Quarterly) for NTLA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

ANI Pharmaceuticals, Inc.	--
Regeneron Pharmaceuticals, Inc.	Upgrade
Beam Therapeutics, Inc.	Upgrade
Vertex Pharmaceuticals, Inc.	--
Pacific Biosciences of California, Inc.	Upgrade